While it is not FDA-approved, clinicians and patients alike are watching it closely because it represents a new direction in peptide therapy for weight loss where its triple-agonist mechanism is something that many did not expect
Jenkins ND, Buckner SL, Cochrane KC, Bergstrom HC, Goldsmith JA, Weir JP, et al
Rare but serious risks include: Pancreatitis : Severe abdominal pain should prompt immediate medical attention Gallbladder problems : Rapid weight loss can increase gallstone risk Diabetic retinopathy complications : In people with existing eye disease, rapid glucose improvement may temporarily worsen retinopathy, particularly with semaglutide [14] [15] Hypoglycaemia : Low blood sugar is uncommon with GLP-1 agonists alone but can occur if combined with insulin or sulphonylureas [17] [18] GLP-1 agonists are not recognised to directly cause dangerous blood pressure drops (hypotension) in most patients
However, many patients enjoy great success with other injection sites as well
The benefits of glutathione are many and widespread
When you receive your product, please look for the Transparency logo and code, which is printed on the products cover
